Regulatory Trends in AI-enabled SaMDs
FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…
FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…
Workforce shortages and growing administrative pressure are placing increasing strain on the NHS, prompting managers to look for practical ways to support overstretched clinicians. According…
Innovation in healthcare advances deliberately, and for good reason. Established clinical practices earn the trust of healthcare professionals by ensuring patient safety, and any change…